Quanterix Corporation Business Combination, Contingent Consideration, Liability, Current
Quanterix Corporation (QTRX) had Business Combination, Contingent Consideration, Liability, Current of $8.13 million as of 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2025-11-10
- 2025-09-30: Business Combination, Contingent Consideration, Liability, Current $8.13M.
- 2025-06-30: Business Combination, Contingent Consideration, Liability, Current $7.90M.
- 2024-12-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2025-09-30 | $8.13M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $7.90M 10-Q · filed 2025-08-07 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |